{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:52:58Z","timestamp":1785858778921,"version":"3.56.0"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1097\/01.crd.0000181618.29506.1e","type":"journal-article","created":{"date-parts":[[2005,10,17]],"date-time":"2005-10-17T05:48:20Z","timestamp":1129528100000},"page":"312-314","source":"Crossref","is-referenced-by-count":18,"title":["Use of Long-Term Combined Therapy With Inhaled Iloprost and Oral Sildenafil in an Adult Patient With Eisenmenger Syndrome"],"prefix":"10.1097","volume":"13","author":[{"given":"Kaan","family":"Okyay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Cemri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bulent","family":"Boyac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rdvan","family":"Yalcn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atiye","family":"Cengel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210203","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJM199602013340504","article-title":"A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension.","volume":"334","author":"Barst","year":"1996","journal-title":"N Engl J Med"},{"key":"R2-8-20210203","doi-asserted-by":"crossref","first-page":"740","DOI":"10.7326\/0003-4819-130-9-199905040-00014","article-title":"Compassionate use of continuous prostacyclin in the management of secondary pulmonary hypertension: a case series.","volume":"130","author":"McLaughlin","year":"1999","journal-title":"Ann Intern Med"},{"key":"R3-8-20210203","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa020204","article-title":"For the aerosolized iloprost randomized study group.","volume":"347","author":"Olschewski","year":"2002","journal-title":"N Engl J Med"},{"key":"R4-8-20210203","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1136\/heart.86.6.661","article-title":"Long term treatment of pulmonary arterial hypertension with beraprost, an oral prostacyclin analogue.","volume":"86","author":"Vizza","year":"2001","journal-title":"Heart"},{"key":"R5-8-20210203","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.jacc.2003.10.056","article-title":"Clinical efficacy of sildenafil in primary pulmonary hypertension: a randomized, placebo-controlled, double-blind, crossover study.","volume":"43","author":"Sastry","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"R6-8-20210203","doi-asserted-by":"crossref","first-page":"515","DOI":"10.7326\/0003-4819-136-7-200204020-00008","article-title":"Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension.","volume":"136","author":"Ghofrani","year":"2002","journal-title":"Ann Intern Med"},{"key":"R7-8-20210203","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1067\/mhj.2002.121267","article-title":"Poor prognosis and related factors in adults with Eisenmenger syndrome.","volume":"143","author":"Oya","year":"2002","journal-title":"Am Heart J"},{"key":"R8-8-20210203","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0002-9149(02)03328-3","article-title":"Usefulness of epoprostenol therapy in the severely ill adolescent\/adult with Eisenmenger physiology.","volume":"91","author":"Fernandes","year":"2003","journal-title":"Am J Cardiol"},{"key":"R9-8-20210203","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.ehj.2004.07.005","article-title":"Responsiveness to inhaled nitric oxide is a predictor for mid-term survival in adult patients with congenital heart defects and pulmonary arterial hypertension.","volume":"25","author":"Post","year":"2004","journal-title":"Eur Heart J"},{"key":"R10-8-20210203","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1097\/01.AOG.0000125148.82698.65","article-title":"Management of Eisenmenger syndrome in pregnancy with sildenafil and l-arginine.","volume":"103","author":"Lacassie","year":"2004","journal-title":"Obstet Gynecol"},{"key":"R11-8-20210203","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.amjcard.2004.03.081","article-title":"Initial experience with bosentan therapy in patients with the Eisenmenger syndrome.","volume":"15","author":"Christensen","year":"2004","journal-title":"Am J Cardiol"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006534-200511000-00045","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:58:08Z","timestamp":1785855488000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00045415-200511000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":11,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1097\/01.crd.0000181618.29506.1e","relation":{},"ISSN":["1061-5377"],"issn-type":[{"value":"1061-5377","type":"print"}],"subject":[],"published":{"date-parts":[[2005,11]]}}}